Duration of Antiviral Prophylaxis and Risk of Herpes Zoster among Patients Receiving Autologous Hematopoietic Stem Cell Transplants: A Retrospective, Observational Study

INTRODUCTION: There are no real-world data on antiviral prophylaxis (AP) duration and risk of herpes zoster (HZ) given AP duration in patients receiving autologous hematopoietic stem cell transplants (auto-HSCT). The objectives of this study are to describe the duration of AP and to compare incidenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Dongmu, Weiss, Thomas, Feng, Yu, Finelli, Lynn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504229/
https://www.ncbi.nlm.nih.gov/pubmed/28508307
http://dx.doi.org/10.1007/s12325-017-0553-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504229/
https://www.ncbi.nlm.nih.gov/pubmed/28508307
http://dx.doi.org/10.1007/s12325-017-0553-4

Ejemplares similares